Literature DB >> 1488958

Trends in the incidence of and mortality from coronary heart disease in Finland, 1983-1988.

V Salomaa1, M Arstila, E Kaarsalo, M Ketonen, K Kuulasmaa, S Lehto, H Miettinen, H Mustaniemi, M Niemelä, P Palomäki.   

Abstract

Trends in the incidence of and mortality from coronary heart disease during the period 1983-1988 were assessed in the population aged 35-64 years in three areas of Finland. The official mortality statistics and the FINMONICA (Finnish portion of the World Health Organization MONICA (Monitoring of Trends and Determinants in Cardiovascular Disease) project) Acute Myocardial Infarction Register were used as data sources. They both showed that coronary heart disease mortality declined steeply in Finnish men and women. This marked decline in coronary heart disease mortality was associated with a decline in the number of out-of-hospital coronary deaths. The changes in the incidence of acute myocardial infarction in men did not parallel the changes in mortality. No decline in incidence was seen in women in any of the study areas. These results suggest that the routine mortality statistics alone may give an overly favorable picture of coronary heart disease trends. Data on incidence are necessary to assess the need for the treatment and prevention of coronary heart disease.

Entities:  

Mesh:

Year:  1992        PMID: 1488958     DOI: 10.1093/oxfordjournals.aje.a116442

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  9 in total

1.  Health-related behaviors in the Republic of Karelia, Russia, and North Karelia, Finland.

Authors:  T K Matilainen; P Puska; M A Berg; S Pokusajeva; N Moisejeva; M Uhanov; A Artemjev
Journal:  Int J Behav Med       Date:  1994

2.  Incidence, recurrence, and case fatality rates for myocardial infarction in southwestern France, 1985 to 1993.

Authors:  P Marques-Vidal; J B Ruidavets; J P Cambou; J Ferrières
Journal:  Heart       Date:  2000-08       Impact factor: 5.994

3.  Comparison of risk factors for coronary heart disease in Dresden and Münster. Results of the DRECAN (Dresden Cardiovascular Risk and Nutrition) study and the PROCAM (Prospective Cardiovascular Münster) Study.

Authors:  W Jaross; G Assmann; S Bergmann; H Schulte
Journal:  Eur J Epidemiol       Date:  1994-06       Impact factor: 8.082

Review 4.  Chlamydia pneumoniae and atherosclerosis.

Authors:  Y K Wong; P J Gallagher; M E Ward
Journal:  Heart       Date:  1999-03       Impact factor: 5.994

5.  Do changes in cardiovascular risk factors explain the increasing socioeconomic difference in mortality from ischaemic heart disease in Finland?

Authors:  E Vartiainen; J Pekkanen; S Koskinen; P Jousilahti; V Salomaa; P Puska
Journal:  J Epidemiol Community Health       Date:  1998-07       Impact factor: 3.710

6.  Does NIDDM increase the risk for coronary heart disease similarly in both low- and high-risk populations?

Authors:  M Laakso; T Rönnemaa; S Lehto; P Puukka; V Kallio; K Pyörälä
Journal:  Diabetologia       Date:  1995-04       Impact factor: 10.122

7.  Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland.

Authors:  P Pajukanta; M Cargill; L Viitanen; I Nuotio; A Kareinen; M Perola; J D Terwilliger; E Kempas; M Daly; H Lilja; J D Rioux; T Brettin; J S Viikari; T Rönnemaa; M Laakso; E S Lander; L Peltonen
Journal:  Am J Hum Genet       Date:  2000-11-13       Impact factor: 11.043

8.  Mortality trends for ischemic heart disease in China: an analysis of 102 continuous disease surveillance points from 1991 to 2009.

Authors:  Xia Wan; Hongyan Ren; Enbo Ma; Gonghuan Yang
Journal:  BMC Public Health       Date:  2017-07-25       Impact factor: 3.295

9.  No association of BMI and body adiposity with cardiometabolic biomarkers among a small sample of reindeer herders of sub-Arctic Finland.

Authors:  Cara Ocobock; Päivi Soppela; Minna T Turunen
Journal:  Int J Circumpolar Health       Date:  2022-12       Impact factor: 1.228

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.